These projections take anticipated discounts, rebates and other price concessions into account, according to Reuters.
IMS sees an annual growth rate of 4 percent to 7 percent through 2020.
Using wholesale prices, U.S. spending on prescription medicines could rise by 46 percent to $640 billion in 2020, according to the report.
IMS’ report found spending on prescription drugs in 2015 increased by 12.2 percent, reaching nearly $425 billion.
More articles on finance:
Geisinger patient refund policy spurs at least 1 health system to consider the idea
Moody’s assigns ‘A3’ rating to CareGroup’s bonds
22 recent hospital outlook and credit rating actions
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
